Endorphins

Endorphins are a family of peptides produced by the body that bind to the same receptors as opioid drugs, reducing pain and generating feelings of well-being. The name is a contraction of endogenous morphine — morphine made from within.

They belong to a broader class of endogenous opioid peptides that includes enkephalins and dynorphins, each with overlapping but distinct roles. Endorphins are released in the brain and pituitary gland in response to pain, physical stress, and intense exercise.

How it works · its role

Endorphins act primarily at mu-opioid receptors, the same receptors that morphine and other opioid drugs target. When they bind, they suppress pain signals travelling up the spinal cord and activate reward circuits in the brain, particularly pathways that release dopamine.

The release is triggered by a wide range of stimuli — sustained exercise, acute injury, emotional stress, and certain foods. The effect is not simply a muting of pain; at higher levels, endorphin release can produce a mild euphoria, the well-known runner's high being one example.

Because endorphins are peptides rather than small molecules, they do not easily cross the blood-brain barrier when given externally. The body's own production, concentrated in the brain and spinal cord, is what drives their central effects.

Relevance to substances & effects

Opioid drugs — including morphine, heroin, oxycodone, and fentanyl — produce their effects precisely because they mimic endorphins at opioid receptors. They bind with high affinity to the same mu-opioid sites, amplifying pain relief and euphoria well beyond what the endogenous system can generate on its own.

This overlap explains why opioids feel reinforcing: they are, in effect, hijacking a system the body uses for survival signalling. Alcohol and some other substances are also thought to stimulate endorphin release indirectly, contributing to their rewarding properties, though the mechanism is less direct.

Ultra-low-dose naltrexone — an opioid receptor blocker — is sometimes used clinically to modulate endorphin signalling, illustrating how tightly this system is tied to mood and pain regulation.

Tolerance & dependence

When opioid receptors are occupied continuously — whether by pharmaceutical opioids or by substances that strongly stimulate endorphin pathways — the system adapts. Receptor density decreases and sensitivity falls, meaning more stimulation is needed to achieve the same effect.

When the drug is removed, the endogenous system is left temporarily under-signalling. The body's own endorphins are no longer sufficient to maintain baseline comfort, and withdrawal — experienced as pain, restlessness, and dysphoria — reflects this gap. Recovery of normal receptor sensitivity takes days to weeks, which is why the early post-discontinuation period is particularly difficult.